14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of WINT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Windtree Therapeutics Inc stock price fell more than -9.30% Wednesday closing at $5.16
(Updated on Apr 24, 2024)

Buy or Hold candidate since Apr 23, 2024 Loss -9.30% PDF

The Windtree Therapeutics Inc stock price fell by -9.30% on the last day (Wednesday, 24th Apr 2024) from $5.68 to $5.16. During the last trading day the stock fluctuated 9.27% from a day low at $4.83 to a day high of $5.28. The price has fallen in 6 of the last 10 days but is still up by 1256.58% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -31 thousand shares and in total, 50 thousand shares were bought and sold for approximately $259.31 thousand.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $5.70 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 30.78% during the next 3 months and, with a 90% probability hold a price between $0.532 and $7.46 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

WINT Signals & Forecast

The Windtree Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.54 and $0.81. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -9.30%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Windtree Therapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.448 between high and low, or 9.27%. For the last week the stock has had daily average volatility of 21.65%.

The Windtree Therapeutics Inc stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $4.89 (-5.22%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 89 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (WINT) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Windtree Therapeutics Inc to open at $5.09, and during the day (based on 14 day Average True Range), to move between $4.66 and $5.65, which gives a possible trading interval of +/-$0.500 (+/-9.70%) up or down from last closing price. If Windtree Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 19.39% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.45, some $0.295 (5.72%) from the current price of $5.16, our system finds the risk reward not very attractive.

Is Windtree Therapeutics Inc stock A Buy?

Windtree Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.886 Hold/Accumulate Downgraded

Predicted Opening Price for Windtree Therapeutics Inc of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$5.09 ( 1.31%) $5.16

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for WINT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.54 7.38 %
R2 5.36 4.06 %
R1 5.26 2.01 %
Current price: 5.16
Support S1 4.92 -4.63 %
S2 4.81 -6.68 %
S3 4.64 -10.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 5.68 10.25 %
R1 5.45 5.72 %
Current price 5.16
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Windtree Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Windtree Therapeutics Inc is WINT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Windtree Therapeutics Inc Stock?
Windtree Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Windtree Therapeutics Inc Stock?
Windtree Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Windtree Therapeutics Inc Stock.

What's the current price of Windtree Therapeutics Inc Stock?
As of the end of day on the Apr 24, 2024, the price of an Windtree Therapeutics Inc (WINT) share was $5.16.

What is the 52-week high and low for Windtree Therapeutics Inc Stock?
The 52-week high for Windtree Therapeutics Inc Stock is $5.95 and the 52-week low is $0.265.

What is the market capitalization of Windtree Therapeutics Inc Stock?
As of the Apr 24, 2024, the market capitalization of Windtree Therapeutics Inc is 3.243M.

When is the next earnings date for Windtree Therapeutics Inc?
The upcoming earnings date for Windtree Therapeutics Inc is May 20, 2024.
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT